Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chiao-Yun Chu"'
Publikováno v:
Molecular medicine reports. 27(2)
Although arsenic is an environmental toxicant, arsenic trioxide (ATO) is used to treat acute promyelocytic leukemia (APL) with anticancer effects. Studies have demonstrated oral cancer is in the top 10 cancers in Taiwan. High rate of oral cancers is
Publikováno v:
Water; Volume 14; Issue 11; Pages: 1712
Membrane bioreactors (MBRs) are widely used to treat wastewater, mainly due to the production of high-quality effluent. However, biofilm forming on the surface of membranes can cause many problems, which remains one of the major limitations of this t
Autor:
Su-Zhen Wu, Yu-Yan Lan, Chiao-Yun Chu, Yang-Kao Wang, Yi-Ping Lee, Hong-Yi Chang, Bu-Miin Huang
Publikováno v:
International journal of oncology. 60(2)
For a number of years, oral cancer has remained in the top ten most common types of cancer, with an incidence rate that is steadily increasing. In total, ~75% oral cancer cases are associated with lifestyle factors, including uncontrolled alcohol con
Autor:
Chiao-Yun Chu, 朱巧芸
107
Quorum quenching (QQ) is one of the biologically strategies for controlling membrane fouling. QQ directly controls the Extracellular polymeric substances (EPS), which is an important polymer causing membrane fouling. The principle of the bac
Quorum quenching (QQ) is one of the biologically strategies for controlling membrane fouling. QQ directly controls the Extracellular polymeric substances (EPS), which is an important polymer causing membrane fouling. The principle of the bac
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/9535c3
Publikováno v:
Cancer Medicine
Nasopharyngeal carcinoma (NPC) can develop cisplatin‐resistant phenotype. Research has revealed that enriched in cancer stem cell population is involved in developing cisplatin‐resistant phenotype. CD271 is a candidate stem cell maker in head and
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966); 6/13/2016, Vol. 35, p1-11, 11p
Autor:
Gao, Wei1, Li, John Zeng‐Hong1,2, Chen, Si‐Qi1, Chu, Chiao‐Yun1, Chan, Jimmy Yu‐Wai1, Wong, Thian‐Sze1 thainsze@gmail.com
Publikováno v:
Cancer Medicine. Feb2017, Vol. 6 Issue 2, p439-451. 13p.
Publikováno v:
Water (20734441); Jun2022, Vol. 14 Issue 11, p1712-1712, 13p
Autor:
Foo, Ning-Ping, Ko, Chi-Lin, Chu, Chiao-Yun, Wang, Chia-Yih, So, Edmund Cheung, Huang, Bu-Miin
Publikováno v:
Oncology Reports; Dec2020, Vol. 44 Issue 6, p2701-2714, 14p
Publikováno v:
Drug Week; 2/17/2023, p1098-1098, 1p